[1]
Curtin SC, Garnett MF. Suicide and Homicide Death Rates Among Youth and Young Adults Aged 10-24: United States, 2001-2021. NCHS data brief. 2023 Jun:(471):1-8
[PubMed PMID: 37367034]
[2]
Garnett MF, Spencer MR, Weeks JD. Suicide Among Adults Age 55 and Older, 2021. NCHS data brief. 2023 Nov:(483):1-8
[PubMed PMID: 38051033]
[3]
Garnett MF, Curtin SC. Suicide Mortality in the United States, 2001-2021. NCHS data brief. 2023 Apr:(464):1-8
[PubMed PMID: 37093258]
[4]
Han B, Crosby AE, Ortega LA, Parks SE, Compton WM, Gfroerer J. Suicidal ideation, suicide attempt, and occupations among employed adults aged 18-64years in the United States. Comprehensive psychiatry. 2016 Apr:66():176-86. doi: 10.1016/j.comppsych.2016.02.001. Epub 2016 Feb 10
[PubMed PMID: 26995251]
[5]
Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. The American journal of psychiatry. 2011 Dec:168(12):1266-77. doi: 10.1176/appi.ajp.2011.10111704. Epub
[PubMed PMID: 22193671]
[6]
Jobes DA, Joiner TE. Reflections on Suicidal Ideation. Crisis. 2019 Jul:40(4):227-230. doi: 10.1027/0227-5910/a000615. Epub
[PubMed PMID: 31274031]
[7]
Courtet P, Baca-García E. Enriching the Assessment of Suicidal Ideation: Learning From Digital Studies. The Journal of clinical psychiatry. 2024 Jan 17:85(1):. pii: 23com15205. doi: 10.4088/JCP.23com15205. Epub 2024 Jan 17
[PubMed PMID: 38236048]
[8]
Pompili M. Persistent suicidal ideation in major depressive disorder patients: still in need of empathic understanding. International clinical psychopharmacology. 2022 Nov 1:37(6):279-280. doi: 10.1097/YIC.0000000000000434. Epub 2022 Sep 14
[PubMed PMID: 36165512]
Level 3 (low-level) evidence
[9]
Mann JJ, Michel CA, Auerbach RP. Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review. The American journal of psychiatry. 2021 Jul:178(7):611-624. doi: 10.1176/appi.ajp.2020.20060864. Epub 2021 Feb 18
[PubMed PMID: 33596680]
Level 1 (high-level) evidence
[10]
Stene-Larsen K, Reneflot A. Contact with primary and mental health care prior to suicide: A systematic review of the literature from 2000 to 2017. Scandinavian journal of public health. 2019 Feb:47(1):9-17. doi: 10.1177/1403494817746274. Epub 2017 Dec 5
[PubMed PMID: 29207932]
Level 1 (high-level) evidence
[11]
Walby FA, Myhre MØ, Kildahl AT. Contact With Mental Health Services Prior to Suicide: A Systematic Review and Meta-Analysis. Psychiatric services (Washington, D.C.). 2018 Jul 1:69(7):751-759. doi: 10.1176/appi.ps.201700475. Epub 2018 Apr 16
[PubMed PMID: 29656710]
Level 1 (high-level) evidence
[12]
Snowdon J, Choi NG. Undercounting of suicides: Where suicide data lie hidden. Global public health. 2020 Dec:15(12):1894-1901. doi: 10.1080/17441692.2020.1801789. Epub 2020 Aug 3
[PubMed PMID: 32744898]
[13]
Oexle N, Waldmann T, Staiger T, Xu Z, Rüsch N. Mental illness stigma and suicidality: the role of public and individual stigma. Epidemiology and psychiatric sciences. 2018 Apr:27(2):169-175. doi: 10.1017/S2045796016000949. Epub 2016 Dec 6
[PubMed PMID: 27919303]
[14]
Fazel S, Runeson B. Suicide. The New England journal of medicine. 2020 Jan 16:382(3):266-274. doi: 10.1056/NEJMra1902944. Epub
[PubMed PMID: 31940700]
[15]
Franklin JC, Ribeiro JD, Fox KR, Bentley KH, Kleiman EM, Huang X, Musacchio KM, Jaroszewski AC, Chang BP, Nock MK. Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research. Psychological bulletin. 2017 Feb:143(2):187-232. doi: 10.1037/bul0000084. Epub 2016 Nov 14
[PubMed PMID: 27841450]
Level 1 (high-level) evidence
[16]
Bayliss LT, Christensen S, Lamont-Mills A, du Plessis C. Suicide capability within the ideation-to-action framework: A systematic scoping review. PloS one. 2022:17(10):e0276070. doi: 10.1371/journal.pone.0276070. Epub 2022 Oct 27
[PubMed PMID: 36301944]
Level 1 (high-level) evidence
[17]
O'Connor RC, Kirtley OJ. The integrated motivational-volitional model of suicidal behaviour. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2018 Sep 5:373(1754):. doi: 10.1098/rstb.2017.0268. Epub
[PubMed PMID: 30012735]
[18]
Klonsky ED, Pachkowski MC, Shahnaz A, May AM. The three-step theory of suicide: Description, evidence, and some useful points of clarification. Preventive medicine. 2021 Nov:152(Pt 1):106549. doi: 10.1016/j.ypmed.2021.106549. Epub 2021 Sep 16
[PubMed PMID: 34538372]
[19]
Pachkowski MC, Hewitt PL, Klonsky ED. Examining suicidal desire through the lens of the three-step theory: A cross-sectional and longitudinal investigation in a community sample. Journal of consulting and clinical psychology. 2021 Jan:89(1):1-10. doi: 10.1037/ccp0000546. Epub
[PubMed PMID: 33507772]
Level 2 (mid-level) evidence
[20]
Bryan CJ, Butner JE, May AM, Rugo KF, Harris J, Oakey DN, Rozek DC, Bryan AO. Nonlinear change processes and the emergence of suicidal behavior: a conceptual model based on the fluid vulnerability theory of suicide. New ideas in psychology. 2020 Apr:57():. doi: 10.1016/j.newideapsych.2019.100758. Epub
[PubMed PMID: 32123464]
[21]
Kuhlman KR, Chiang JJ, Horn S, Bower JE. Developmental psychoneuroendocrine and psychoneuroimmune pathways from childhood adversity to disease. Neuroscience and biobehavioral reviews. 2017 Sep:80():166-184. doi: 10.1016/j.neubiorev.2017.05.020. Epub 2017 May 31
[PubMed PMID: 28577879]
[22]
Menke A. Is the HPA Axis as Target for Depression Outdated, or Is There a New Hope? Frontiers in psychiatry. 2019:10():101. doi: 10.3389/fpsyt.2019.00101. Epub 2019 Feb 28
[PubMed PMID: 30890970]
[23]
O'Connor DB, Green JA, Ferguson E, O'Carroll RE, O'Connor RC. Cortisol reactivity and suicidal behavior: Investigating the role of hypothalamic-pituitary-adrenal axis responses to stress in suicide attempters and ideators. Psychoneuroendocrinology. 2017 Jan:75():183-191. doi: 10.1016/j.psyneuen.2016.10.019. Epub 2016 Oct 24
[PubMed PMID: 27837698]
[24]
Suzuki H, Ohgidani M, Kuwano N, Chrétien F, Lorin de la Grandmaison G, Onaya M, Tominaga I, Setoyama D, Kang D, Mimura M, Kanba S, Kato TA. Suicide and Microglia: Recent Findings and Future Perspectives Based on Human Studies. Frontiers in cellular neuroscience. 2019:13():31. doi: 10.3389/fncel.2019.00031. Epub 2019 Feb 13
[PubMed PMID: 30814929]
Level 3 (low-level) evidence
[25]
Serafini G, Adavastro G, Canepa G, Capobianco L, Conigliaro C, Pittaluga F, Murri MB, Valchera A, De Berardis D, Pompili M, Lindqvist D, Brundin L, Amore M. Abnormalities in Kynurenine Pathway Metabolism in Treatment-Resistant Depression and Suicidality: A Systematic Review. CNS & neurological disorders drug targets. 2017:16(4):440-453. doi: 10.2174/1871527316666170413110605. Epub
[PubMed PMID: 28412922]
Level 1 (high-level) evidence
[26]
De Berardis D, Fornaro M, Valchera A, Cavuto M, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Fiengo A, Ventriglio A, Yong-Ku K, Martinotti G, Di Giannantonio M, Tomasetti C. Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors. International journal of molecular sciences. 2018 Sep 23:19(10):. doi: 10.3390/ijms19102888. Epub 2018 Sep 23
[PubMed PMID: 30249029]
[27]
Holmes SE, Hinz R, Conen S, Gregory CJ, Matthews JC, Anton-Rodriguez JM, Gerhard A, Talbot PS. Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study. Biological psychiatry. 2018 Jan 1:83(1):61-69. doi: 10.1016/j.biopsych.2017.08.005. Epub 2017 Aug 12
[PubMed PMID: 28939116]
[28]
Fernandes BS, Steiner J, Berk M, Molendijk ML, Gonzalez-Pinto A, Turck CW, Nardin P, Gonçalves CA. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Molecular psychiatry. 2015 Sep:20(9):1108-19. doi: 10.1038/mp.2014.117. Epub 2014 Sep 30
[PubMed PMID: 25266124]
Level 1 (high-level) evidence
[29]
Zhang L, Hu XZ, Benedek DM, Fullerton CS, Forsten RD, Naifeh JA, Li X, Biomarker Study Group. Genetic predictor of current suicidal ideation in US service members deployed to Iraq and Afghanistan. Journal of psychiatric research. 2019 Jun:113():65-71. doi: 10.1016/j.jpsychires.2019.03.007. Epub 2019 Mar 17
[PubMed PMID: 30904785]
[30]
Hernández-Díaz Y, González-Castro TB, Tovilla-Zárate CA, Juárez-Rojop IE, López-Narváez ML, Pérez-Hernández N, Rodríguez-Pérez JM, Genis-Mendoza AD. Association between FKBP5 polymorphisms and depressive disorders or suicidal behavior: A systematic review and meta-analysis study. Psychiatry research. 2019 Jan:271():658-668. doi: 10.1016/j.psychres.2018.12.066. Epub 2018 Dec 10
[PubMed PMID: 30791339]
Level 1 (high-level) evidence
[31]
Mann JJ. A current perspective of suicide and attempted suicide. Annals of internal medicine. 2002 Feb 19:136(4):302-11
[PubMed PMID: 11848728]
Level 3 (low-level) evidence
[32]
Tøllefsen IM, Helweg-Larsen K, Thiblin I, Hem E, Kastrup MC, Nyberg U, Rogde S, Zahl PH, Østevold G, Ekeberg Ø. Are suicide deaths under-reported? Nationwide re-evaluations of 1800 deaths in Scandinavia. BMJ open. 2015 Nov 25:5(11):e009120. doi: 10.1136/bmjopen-2015-009120. Epub 2015 Nov 25
[PubMed PMID: 26608638]
[33]
Oquendo MA, Volkow ND. Suicide: A Silent Contributor to Opioid-Overdose Deaths. The New England journal of medicine. 2018 Apr 26:378(17):1567-1569. doi: 10.1056/NEJMp1801417. Epub
[PubMed PMID: 29694805]
[34]
Bilsen J. Suicide and Youth: Risk Factors. Frontiers in psychiatry. 2018:9():540. doi: 10.3389/fpsyt.2018.00540. Epub 2018 Oct 30
[PubMed PMID: 30425663]
[35]
Rizvi A, Usmani MA, Husain K, Yadava D. Emergency department visits for self-harm in the USA: Cross sectional study of National Hospital Ambulatory Medical Care Survey 2016-2020. General hospital psychiatry. 2023 Sep-Oct:84():258-259. doi: 10.1016/j.genhosppsych.2023.06.004. Epub 2023 Jun 10
[PubMed PMID: 37328361]
Level 3 (low-level) evidence
[36]
Hedegaard H, Curtin SC, Warner M. Suicide Mortality in the United States, 1999-2017. NCHS data brief. 2018 Nov:(330):1-8
[PubMed PMID: 30500324]
[37]
Sher L, Oquendo MA. Suicide: An Overview for Clinicians. The Medical clinics of North America. 2023 Jan:107(1):119-130. doi: 10.1016/j.mcna.2022.03.008. Epub 2022 Oct 28
[PubMed PMID: 36402494]
Level 3 (low-level) evidence
[38]
Dazzi T, Gribble R, Wessely S, Fear NT. Does asking about suicide and related behaviours induce suicidal ideation? What is the evidence? Psychological medicine. 2014 Dec:44(16):3361-3. doi: 10.1017/S0033291714001299. Epub 2014 Jul 7
[PubMed PMID: 24998511]
[39]
Norris DR, Clark MS. The Suicidal Patient: Evaluation and Management. American family physician. 2021 Apr 1:103(7):417-421
[PubMed PMID: 33788523]
[40]
Sall J, Brenner L, Millikan Bell AM, Colston MJ. Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. Annals of internal medicine. 2019 Sep 3:171(5):343-353. doi: 10.7326/M19-0687. Epub 2019 Aug 27
[PubMed PMID: 31450237]
Level 1 (high-level) evidence
[41]
Sarkhel S, Vijayakumar V, Vijayakumar L. Clinical Practice Guidelines for Management of Suicidal Behaviour. Indian journal of psychiatry. 2023 Feb:65(2):124-130. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_497_22. Epub 2023 Jan 30
[PubMed PMID: 37063624]
Level 1 (high-level) evidence
[42]
Andreotti ET, Ipuchima JR, Cazella SC, Beria P, Bortoncello CF, Silveira RC, Ferrão YA. Instruments to assess suicide risk: a systematic review. Trends in psychiatry and psychotherapy. 2020 Jul-Sep:42(3):276-281. doi: 10.1590/2237-6089-2019-0092. Epub
[PubMed PMID: 32997043]
Level 1 (high-level) evidence
[43]
Austria-Corrales F, Jiménez-Tapia A, Astudillo-García CI, Arenas-Landgrave P, Xochihua-Tlecuitl T, Cruz-Cruz C, Rivera-Rivera L, Gómez-García JA, Palacios-Hernández B, Pérez-Amezcua B, Toledano-Toledano F, Richards J, Galynker I. The Columbia-suicide severity rating scale: validity and psychometric properties of an online Spanish-language version in a Mexican population sample. Frontiers in public health. 2023:11():1157581. doi: 10.3389/fpubh.2023.1157581. Epub 2023 Sep 5
[PubMed PMID: 37732099]
[44]
van Spijker BA, Batterham PJ, Calear AL, Farrer L, Christensen H, Reynolds J, Kerkhof AJ. The suicidal ideation attributes scale (SIDAS): Community-based validation study of a new scale for the measurement of suicidal ideation. Suicide & life-threatening behavior. 2014 Aug:44(4):408-19. doi: 10.1111/sltb.12084. Epub 2014 Feb 24
[PubMed PMID: 24612048]
Level 1 (high-level) evidence
[45]
Collings S, Jenkin G, Stanley J, McKenzie S, Hatcher S. Preventing suicidal behaviours with a multilevel intervention: a cluster randomised controlled trial. BMC public health. 2018 Jan 16:18(1):140. doi: 10.1186/s12889-018-5032-6. Epub 2018 Jan 16
[PubMed PMID: 29338723]
Level 1 (high-level) evidence
[46]
Shah R, Franks P, Jerant A, Feldman M, Duberstein P, Fernandez y Garcia E, Hinton L, Strohecker L, Kravitz RL. The effect of targeted and tailored patient depression engagement interventions on patient-physician discussion of suicidal thoughts: a randomized control trial. Journal of general internal medicine. 2014 Aug:29(8):1148-54. doi: 10.1007/s11606-014-2843-8. Epub 2014 Apr 8
[PubMed PMID: 24710994]
Level 1 (high-level) evidence
[47]
Hawton K, Witt KG, Taylor Salisbury TL, Arensman E, Gunnell D, Hazell P, Townsend E, van Heeringen K. Psychosocial interventions for self-harm in adults. The Cochrane database of systematic reviews. 2016 May 12:2016(5):CD012189. doi: 10.1002/14651858.CD012189. Epub 2016 May 12
[PubMed PMID: 27168519]
Level 1 (high-level) evidence
[48]
Bryan CJ, Mintz J, Clemans TA, Leeson B, Burch TS, Williams SR, Maney E, Rudd MD. Effect of crisis response planning vs. contracts for safety on suicide risk in U.S. Army Soldiers: A randomized clinical trial. Journal of affective disorders. 2017 Apr 1:212():64-72. doi: 10.1016/j.jad.2017.01.028. Epub 2017 Jan 23
[PubMed PMID: 28142085]
Level 1 (high-level) evidence
[49]
Salkovskis PM, Atha C, Storer D. Cognitive-behavioural problem solving in the treatment of patients who repeatedly attempt suicide. A controlled trial. The British journal of psychiatry : the journal of mental science. 1990 Dec:157():871-6
[PubMed PMID: 2289097]
[50]
Hawton K, Townsend E, Arensman E, Gunnell D, Hazell P, House A, van Heeringen K. Psychosocial versus pharmacological treatments for deliberate self harm. The Cochrane database of systematic reviews. 2000:(2):CD001764
[PubMed PMID: 10796818]
Level 1 (high-level) evidence
[51]
Spielmans GI, Spence-Sing T, Parry P. Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified. Frontiers in psychiatry. 2020:11():18. doi: 10.3389/fpsyt.2020.00018. Epub 2020 Feb 13
[PubMed PMID: 32116839]
[52]
Li K, Zhou G, Xiao Y, Gu J, Chen Q, Xie S, Wu J. Risk of Suicidal Behaviors and Antidepressant Exposure Among Children and Adolescents: A Meta-Analysis of Observational Studies. Frontiers in psychiatry. 2022:13():880496. doi: 10.3389/fpsyt.2022.880496. Epub 2022 May 26
[PubMed PMID: 35693956]
Level 1 (high-level) evidence
[53]
Abbar M, Demattei C, El-Hage W, Llorca PM, Samalin L, Demaricourt P, Gaillard R, Courtet P, Vaiva G, Gorwood P, Fabbro P, Jollant F. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial. BMJ (Clinical research ed.). 2022 Feb 2:376():e067194. doi: 10.1136/bmj-2021-067194. Epub 2022 Feb 2
[PubMed PMID: 35110300]
Level 1 (high-level) evidence
[54]
Baldaçara L, Grudtner RR, da S Leite V, Porto DM, Robis KP, Fidalgo TM, Rocha GA, Diaz AP, Meleiro A, Correa H, Tung TC, Malloy-Diniz L, Quevedo J, da Silva AG. Brazilian Psychiatric Association guidelines for the management of suicidal behavior. Part 2. Screening, intervention, and prevention. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). 2021 Sep-Oct:43(5):538-549. doi: 10.1590/1516-4446-2020-1108. Epub
[PubMed PMID: 33331533]
[55]
Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, Hough D, Drevets WC, Manji H, Canuso CM. Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II). The international journal of neuropsychopharmacology. 2021 Jan 20:24(1):22-31. doi: 10.1093/ijnp/pyaa068. Epub
[PubMed PMID: 32861217]
Level 1 (high-level) evidence
[56]
Nierenberg AA, Agustini B, Köhler-Forsberg O, Cusin C, Katz D, Sylvia LG, Peters A, Berk M. Diagnosis and Treatment of Bipolar Disorder: A Review. JAMA. 2023 Oct 10:330(14):1370-1380. doi: 10.1001/jama.2023.18588. Epub
[PubMed PMID: 37815563]
[57]
Correll CU, Agid O, Crespo-Facorro B, de Bartolomeis A, Fagiolini A, Seppälä N, Howes OD. A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia. CNS drugs. 2022 Jul:36(7):659-679. doi: 10.1007/s40263-022-00932-2. Epub 2022 Jun 27
[PubMed PMID: 35759211]
[58]
Dadiomov D, Lee K. The effects of ketamine on suicidality across various formulations and study settings. The mental health clinician. 2019 Jan:9(1):48-60. doi: 10.9740/mhc.2019.01.048. Epub 2019 Jan 4
[PubMed PMID: 30627504]
[59]
Sale E, Hendricks M, Weil V, Miller C, Perkins S, McCudden S. Counseling on Access to Lethal Means (CALM): An Evaluation of a Suicide Prevention Means Restriction Training Program for Mental Health Providers. Community mental health journal. 2018 Apr:54(3):293-301. doi: 10.1007/s10597-017-0190-z. Epub 2017 Nov 28
[PubMed PMID: 29185154]
[60]
Wolf LA, Delao AM, Perhats C, Clark PR, Moon MD, Zavotsky KE, Martinovich Z. Emergency Nurses' Perceptions of Risk for Firearm Injury and its Effect on Assessment Practices: A Mixed Methods Study. Journal of emergency nursing. 2019 Jan:45(1):54-66.e2. doi: 10.1016/j.jen.2018.09.010. Epub 2018 Oct 24
[PubMed PMID: 30529291]
[61]
Pistone I, Beckman U, Eriksson E, Lagerlöf H, Sager M. The effects of educational interventions on suicide: A systematic review and meta-analysis. The International journal of social psychiatry. 2019 Aug:65(5):399-412. doi: 10.1177/0020764019852655. Epub 2019 Jun 4
[PubMed PMID: 31159627]
Level 1 (high-level) evidence
[62]
Maulik PK, Devarapalli S, Kallakuri S, Praveen D, Jha V, Patel A. Systematic Medical Appraisal, Referral and Treatment (SMART) Mental Health Programme for providing innovative mental health care in rural communities in India. Global mental health (Cambridge, England). 2015:2():e13. doi: 10.1017/gmh.2015.11. Epub 2015 Jul 29
[PubMed PMID: 28596861]
Level 1 (high-level) evidence
[63]
Molina N, Viola M, Rogers M, Ouyang D, Gang J, Derry H, Prigerson HG. Suicidal Ideation in Bereavement: A Systematic Review. Behavioral sciences (Basel, Switzerland). 2019 May 14:9(5):. doi: 10.3390/bs9050053. Epub 2019 May 14
[PubMed PMID: 31091772]
Level 1 (high-level) evidence
[64]
Stehman CR, Testo Z, Gershaw RS, Kellogg AR. Burnout, Drop Out, Suicide: Physician Loss in Emergency Medicine, Part I. The western journal of emergency medicine. 2019 May:20(3):485-494. doi: 10.5811/westjem.2019.4.40970. Epub 2019 Apr 23
[PubMed PMID: 31123550]
[65]
Witt K, Boland A, Lamblin M, McGorry PD, Veness B, Cipriani A, Hawton K, Harvey S, Christensen H, Robinson J. Effectiveness of universal programmes for the prevention of suicidal ideation, behaviour and mental ill health in medical students: a systematic review and meta-analysis. Evidence-based mental health. 2019 May:22(2):84-90. doi: 10.1136/ebmental-2019-300082. Epub 2019 Mar 27
[PubMed PMID: 30918000]
Level 1 (high-level) evidence